Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Long Focus Capital Management, LLC LAB Standard Biotools Inc. 13G 6% 3mo
Decagon Asset Management LLP OACC Oaktree Acquisition Corp. III Life Sciences 13G 5.52% 3mo
T. Rowe Price Investment Management, Inc. GLNG Golar Lng Ltd 13G 6.2% 3mo
Strategic EP, LLC PDC Perpetuals.com Ltd 13G/A 9.9% 3mo
Alyeska Investment Group, L.P. EXYN Exyn Technologies, Inc. 13G 9.73% 3mo
ARMISTICE CAPITAL, LLC EVGN Evogene Ltd. 13G/A 4.99% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC AESP Aeon Acquisition I Corp. 13G 7.6% 3mo
Squadron Capital Management LLC NXTC NextCure, Inc. 13G/A 1.6% 3mo
Fort Baker Capital Management LP GTEN Gores Holdings X, Inc. 13G/A 9.3% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ SHLS Shoals Technologies Group, Inc. 13G/A 12.9% 3mo
ARMISTICE CAPITAL, LLC VSEE Vsee Health, Inc. 13G/A 7.33% 3mo
Karpus Management, Inc. OXLC Oxford Lane Capital Corp. 13G/A 1.98% 3mo
ALLIANCEBERNSTEIN L.P. WAFD Wafd Inc 13G 5.2% 3mo
FULLER & THALER ASSET MANAGEMENT, INC. PRIM Primoris Services Corp 13G/A 0% 3mo
OSAIC HOLDINGS, INC. GDO Western Asset Global Corporate Opportunity Fund Inc. 13G/A 2.5% 3mo
Hood River Capital Management LLC LPTH Lightpath Technologies Inc 13G 5.37% 3mo
Commodore Capital LP VTGN Vistagen Therapeutics, Inc. 13G/A 9.9% 3mo
Nantahala Capital Management, LLC ELOX Eloxx Pharmaceuticals, Inc. 13G 9.91% 3mo
RA CAPITAL MANAGEMENT, L.P. BCRX Biocryst Pharmaceuticals Inc 13G/A 6.2% 3mo
Zimmer Partners, LP YORW York Water Co 13G/A 8.8% 3mo
TENOR CAPITAL MANAGEMENT Co., L.P. CCAQ Collective Acquisition Corp. 13G/A 0% 3mo
Alyeska Investment Group, L.P. USAR USA Rare Earth, Inc. 13G/A 4.61% 3mo
Durable Capital Partners LP RBC RBC Bearings INC 13G/A 5.4% 3mo
ARMISTICE CAPITAL, LLC CTOR Citius Oncology, Inc. 13G/A 9.99% 3mo
ALLIANCEBERNSTEIN L.P. TNC Tennant Co 13G 7.1% 3mo
Parvus Asset Management Jersey Ltd FLUT Flutter Entertainment plc 13G/A 8.8% 3mo
Balyasny Asset Management L.P. CLRB Cellectar Biosciences, Inc. 13G 9.99% 3mo
T. Rowe Price Investment Management, Inc. TFX Teleflex Inc 13G/A 7.2% 3mo
BAMCO INC /NY/ MORN Morningstar, Inc. 13G 9.2% 3mo
G1 Execution Services, LLC POET Poet Technologies Inc. 13G 5.7% 3mo
Anson Funds Management LP VENU Venu Holding Corp 13G 8.4% 3mo
ARMISTICE CAPITAL, LLC ARDS Aridis Pharmaceuticals Inc. Common Stock 13G/A 11.43% 3mo
Balyasny Asset Management L.P. TXNM Txnm Energy Inc 13G/A 6.43% 3mo
T. Rowe Price Investment Management, Inc. NP Neptune Insurance Holdings Inc. 13G/A 6.1% 3mo
FULLER & THALER ASSET MANAGEMENT, INC. SAIC Science Applications International Corp 13G/A 6.99% 3mo
Callodine Capital Management, LP SPB Spectrum Brands Holdings, Inc. 13G/A 7.56% 3mo
Orbis Investment Management Limited IMAX Imax Corp 13G/A 9.3% 3mo
First Trust Capital Management L.P. BLFY Blue Foundry Bancorp 13G/A 0% 3mo
American Century Investment Management, Inc. ATKR Atkore Inc. 13G 5.3% 3mo
ADAR1 Capital Management, LLC JATT JATT II Acquisition Corp. 13G 5.4% 3mo
T. Rowe Price Investment Management, Inc. NI Nisource Inc. 13G/A 6.2% 3mo
Atreides Management, LP ACVA ACV Auctions Inc. 13G/A 5.7% 3mo
Two Seas Capital LP NKTR Nektar Therapeutics 13G/A 9.1% 3mo
CANADA PENSION PLAN INVESTMENT BOARD CHWY Chewy, Inc. 13G 8.7% 3mo
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. IMAX Imax Corp 13G/A 5.4% 3mo
LAZARD ASSET MANAGEMENT LLC CAF Morgan Stanley China A Share Fund, Inc. 13G 13.1% 3mo
Sessa Capital IM, L.P. SENS Senseonics Holdings, Inc. 13G 9.9% 3mo
GATE CITY CAPITAL MANAGEMENT, LLC CLW Clearwater Paper Corp 13G 5.8% 3mo
Sirenia Capital Management LP TRAW Traws Pharma, Inc. 13G 9.9% 3mo
CLEAR STREET LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G 7.6% 3mo